Cervical cancer: open trials in Netherlands

19 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Amsterdam UMC Locatie VUMC, Amsterdam · Universitair Medisch Centrum Groningen, Groningen · Leids Universitair Medisch Centrum, Leiden · Maastricht University Medical Center, Maastricht · Radboud University Medical Center, Nijmegen
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Amsterdam UMC Stichting, Amsterdam · Universitair Medisch Centrum Groningen, Groningen · Radboud Universitair Medisch Centrum (Radboudumc), Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-10-26
NCT07435987
Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy
Trial Treatment · Erasmus Medical Center
Erasmus Medical Center, Rotterdam
Registry updated 2026-09-25
NCT07782164
Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
Research · Amsterdam UMC, location VUmc
Amsterdam UMC, Amsterdam
Registry updated 2026-08-28
2023-506400-99-00
Phase II randomized study evaluating a Pragmatic approach to Adoptive Cell Therapy (ACT) using an IL2 analog (ANV419/ANV600) vs High dose IL2 after Tumor Infiltrating Lymphocytes (TIL) Therapy in patients with melanoma, NSCLC and cervical cancer. The PragmaTIL
Trial Treatment · Phase 2 · Vall D Hebron Institute Of Oncology
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam
Registry updated 2026-07-23
NCT05768139
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Eli Lilly and Company
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2026-07-07
NCT07645625
Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer
Trial Treatment · Phase 4 · University Medical Center Groningen
Antoni van Leeuwenhoek Ziekenhuis, Amsterdam · Amsterdam UMC, Amsterdam · Catharina Ziekenhuis, Eindhoven · Medisch Spectrum Twente, Enschede · University Mecdical Center Groningen, Groningen · LUMC, Leiden · Maastricht UMC, Maastricht · Radboud UMC, Nijmegen · Erasmus MC, Rotterdam · UMC Utrecht, Utrecht · Isala Klinieken, Zwolle
Registry updated 2026-06-29
NCT07653503
Neoadjuvant Lymph Node Targeted Immunotherapy in Cervical Cancer: a Feasibility Study (NEOLYNC)
Trial Treatment · Phase 1 · University Medical Center Groningen
University Medical Centre Groningen, Groningen
Registry updated 2026-06-17
2024-516870-31-00
A Phase 1 Open-label Study to Evaluate the Safety and Efficacy of MK‑8294 Monotherapy in Advanced Solid Tumors
Trial Treatment · Phase 1 · Merck Sharp & Dohme LLC
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam · Radboud universitair medisch centrum Stichting, Nijmegen
Registry updated 2026-05-28
2025-522883-34-00
PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer
Trial Treatment · Phase 4 · Universitair Medisch Centrum Groningen
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam · Amsterdam UMC Stichting, Amsterdam · Catharina Ziekenhuis Stichting, Eindhoven · Medisch Spectrum Twente, Enschede · Universitair Medisch Centrum Groningen, Groningen · Leids Universitair Medisch Centrum (LUMC), Leiden · Academisch Ziekenhuis Maastricht, Maastricht · Radboud universitair medisch centrum Stichting, Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht · Isala Klinieken Stichting, Zwolle
Registry updated 2026-05-11
NCT07368985
Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer
Trial Treatment · Phase 2 · Prof. Dr. Remi A. Nout
Erasmus MC, Rotterdam
Registry updated 2026-01-27
2025-521771-31-00
Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer
Trial Treatment · Phase 1 · Universitair Medisch Centrum Groningen
Universitair Medisch Centrum Groningen, Groningen
Registry updated 2025-08-19
NCT04016389
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
Trial Treatment · Phase 2 · University Health Network, Toronto
Amsterdam UMC, Amsterdam · Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam · Catharina Ziekenhuis Stichting, Eindhoven · Universitair Medisch Centrum Groningen, Groningen · Leids Universitair Medisch Centrum (LUMC), Leiden · University Hospital Maastricht, Maastricht · Stichting Radboud University Medical Center, Nijmegen · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2025-08-12
NCT06691776
Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)
Trial Treatment · The Netherlands Cancer Institute
Antoni van Leeuwenhoek Hospital, Amsterdam
Registry updated 2025-08-01
NCT05062707
Early Ageing During Therapy in AYA Cancer Patients
Research · University Medical Center Groningen
University Medical Center Groningen, Groningen
Registry updated 2025-05-13
NCT02733289
Standard Follow-up Program Cervix Cancer (SFP CERVIX)
Research · University Medical Center Groningen
University Medical Center Groningen, Groningen
Registry updated 2024-02-28
NCT04475354
Distress In CErvical Cancer Patients and Partners
Research · Comprehensive Cancer Centre The Netherlands
Amphia, Breda · Catharina hospital, Eindhoven · University Medical Center Groningen, Groningen · MUMC+, Maastricht · Radboudumc, Nijmegen · UMC Utrecht, Utrecht
Registry updated 2023-12-06
NCT05406856
PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer
Trial Treatment · Leiden University Medical Center
Leiden University Medical Center, Leiden · Erasmus Medical Center, Rotterdam
Registry updated 2023-10-11
NCT05937958
MRLinac Boost for Gynecological Cancers if Brachytherapy is Not Feasible (MARGARITA)
Research · UMC Utrecht
UMC Utrecht, Utrecht
Registry updated 2023-07-18

All Cervical cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error